New procedure for patients with deep-seated brain tumors, hemorrhages and cysts
May 3, 2013
St.Vincent Health System
INDIANAPOLIS – Dr. Ronald Young, neurosurgeon with Goodman Campbell Brain and Spine at St.Vincent Neuroscience Institute is the first in Indiana and is among a select group of physicians in the United States recently trained to remove cancerous and non-cancerous brain tumors, hemorrhages and cysts located deep in the brain by using a new minimally invasive surgical technology called NICO BrainPath®. The new device, developed in Indianapolis, is integrated with the Six Pillar Approach – a new surgical technique that combines several advanced technologies in the areas of brain mapping, imaging, optics, access and resection.
Ray Motluck, 67 of Noblesville, was first diagnosed with prostate cancer when cancerous tumors spread to his lungs and brain. The tumors in his prostate and lungs were treated through radiation; however, his brain tumor was located deep within his brain. Such a tumor, until now, was previously unreachable with surgery. Since Motluck's surgery with the NICO BrainPath, the Noblesville native has made a full recovery as a result of removing the entire tumor.
The BrainPath uniquely allows the ability to access and remove deep-seated brain tumors and cysts through narrow corridors using a minimally invasive surgical approach that is comparable to the advancements from open knee surgery to minimally invasive arthroscopic knee surgery.
Traditionally, brain tumors can be surgically removed when they are located close to the skull. But, if a tumor is located deep within the brain, it is typically not considered accessible via surgery, until now using the BrainPath. This new surgery option provides patients with less risks of affecting speech, memory, muscle weakness, balance, vision coordination and other function areas. The new procedure also lessens the risk of blood clots, seizures, infection in the brain, and reduces recovery time, pain medication and the length of hospital stay for recovery.
The BrainPath navigates through millions of brain fibers to access deep areas of the brain where deadly brain tumors and hemorrhages may occur. Then, tissue is removed and collected using the NICO Myriad® – all through an opening smaller than the size of a dime.
The NICO BrainPath is part of the Six Pillars that allows for successful minimally invasive brain surgery. The Six Pillars are: mapping of the brain; navigating the brain like a GPS system; safely accessing the brain and tumor using the BrainPath; surgeons using high-end optics for visualization; successfully removing the tumor without disrupting tissues around it using the NICO Myriad; and directed therapy using tissue collected for evaluation that can then be used for personalized medication treatments.
Candidates for the NICO BrainPath are patients whose tumors or hemorrhages are located deep within the brain.
For more information on the NICO BrainPath, visit NICO Neuro and Spine at www.NICOneuro.com.
St.Vincent Hospitals and Health Services
Driven by the faith of four Daughters of Charity who arrived in Indianapolis in 1881 with $34.77 in their pockets, the St.Vincent Hospital mission is to treat the poor and sick by following our Core Values of Service of the Poor, Reverence, Integrity, Wisdom, Creativity and Dedication. Our healthcare ministry has grown to include seven Centers of Excellence: Women's, Children's, Orthopedics, Cardiovascular, Neuroscience, Cancer Care and Bariatrics.; The ageless mission of St.Vincent remains unchanged: to minister to the minds, bodies and spirits of those in need.
NICO Neuro and Spine
NICO Corporation, formed in 2007, is progressing minimally invasive corridor neurosurgery by creating instruments that allow for access through smaller openings and resection of soft tissue abnormalities in the central nervous system. It is the goal of NICO Corporation to develop new technologies in market segments addressing metastatic brain cancer, intracerebral hemorrhages, glioblastoma multiforme, skull base and intraventricular abnormalities that comprise approximately 500,000 procedures in the U.S. annually and 2.3 million worldwide.